Intelligent bio solutions partners with b2i digital to amplify investor outreach

New york, oct. 31, 2024 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (“inbs” or the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a strategic partnership with b2i digital to launch an investor-focused marketing campaign. b2i digital will employ advanced digital marketing strategies to raise awareness of inbs' patented drug screening technology, which offers a fast, non-invasive, and efficient alternative to traditional drug tests.
INBS Ratings Summary
INBS Quant Ranking